🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Improving the quality of life and achieving Treatment-Free Remission(TFR) i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-07-31
Trial ID
NCT05440747
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of flumatin...
Status
Unknown
Location
The Second People's Hospital of Shenzhen
Start Date
2021-01-01
Trial ID
NCT04677439
Treatments Being Tested
Flumatinib is an orally available TKI with high selectivity and potency aga...
Status
Not Yet Recruiting
Location
Institute of Hematology and Oncology, Harbin The First Hospital
Start Date
2022-04-30
Trial ID
NCT05367765
Treatments Being Tested
Multi-center, single stage, phase II study to evaluate the efficacy and saf...
Status
Unknown
Location
Union Hospital Tongji Medical College Huazhong University of Science and technology
Start Date
2013-01
Trial ID
NCT02511340
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of azaciti...
Status
Completed
Location
The First Affiliated Hospital of Soochow University
Start Date
2022-05-01
Trial ID
NCT05433532
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of switchin...
Status
Unknown
Location
Shenzhen Second People's Hospital
Start Date
2021-07-01
Trial ID
NCT04933526
Treatments Being Tested
The overall survival (OS)of Chronic myeloid leukemia (CML) has been signifi...
Status
Unknown
Location
NanfangH
Start Date
2020-12-09
Trial ID
NCT04591197
The ultimate goal of CML treatment is to improve survival, including overal...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Start Date
2020-09-25
Trial ID
NCT04739826
Treatments Being Tested
Philadelphia chromosome (BCR-ABL1, Ph) is the most common genetic abnormali...
Status
Unknown
Location
Department of Hematology, Zhongda Hospital Southeast University, Institute of Hematology Southeast University
Start Date
2020-03-01
Trial ID
NCT04375683
Treatments Being Tested
A study to observe the efficacy and the safety of Flumatinib vs Imatinib as...
Status
Completed
Location
Hospital of Blood Diseases, Chinese Academy of Medical Sciences
Start Date
2014-06
Trial ID
NCT02204644
Treatments Being Tested